A Safety and Pharmacokinetics Study in Participants With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of this antibody in
participants with rheumatoid arthritis.
Part A of the study is an initial dose escalation phase
Part B of the study is a randomized allocation of the entire dosing group to parallel
treatment assignments